| Authors: |
Burke RM; Global Development Division, Bill & Melinda Gates Foundation, Seattle, WA, USA., Ramani S; Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, TX, USA., Lynch J; Office of the Director General, International Vaccine Institute, Seoul, Republic of Korea., Cooper LV; School of Public Health, Imperial College London, London, UK., Cho H; Department of Data Science and Innovation, International Vaccine Institute, Seoul, Republic of Korea., Bandyopadhyay AS; Global Development Division, Bill & Melinda Gates Foundation, Seattle, WA, USA., Kirkwood CD; Global Health Division, Bill & Melinda Gates Foundation, Seattle, WA, USA., Steele AD; Global Health Division, Bill & Melinda Gates Foundation, Seattle, WA, USA., Kang G; Global Health Division, Bill & Melinda Gates Foundation, Seattle, WA, USA. |
